RECURRENT SQUAMOUS CELL CARCINOMA
Clinical trials for RECURRENT SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation therapy shows promise for tough skin cancers
Disease control Recruiting nowThis study tests a new type of radiation therapy (DaRT) for people with recurrent squamous cell skin cancer that has not responded to standard treatments. About 86 participants will receive the treatment directly into their tumors. The goal is to see if the tumors shrink and how …
Matched conditions: RECURRENT SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
New triple-drug attack targets hard-to-treat head and neck cancers
Disease control Recruiting nowThis early-phase study tests a new three-drug combination (zanzalintinib, pembrolizumab, and cetuximab) in adults with recurrent or metastatic head and neck cancer that cannot be cured by local treatments. The main goal is to find the safest dose and check for early signs of tumo…
Matched conditions: RECURRENT SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 14, 2026 12:05 UTC